Primary biliary cholangitis: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• PPAR 0
• TLR4 0
• AKT 0
• EGFR 0
• ERK 0
• GLP-1 0
• JAK 0
• JNK 0
• MDM2 0
• mTOR 0
• NLRP3 0
• PCSK9 0
• PD-1 0
• RUNX1 0
• STING 0
• TP53 0
• YAP 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Organoids 1
• Mendelian Randomization Analysis 16
• Gene Expression Profiling 5
• Proteomics 5
• Metabolomics 4
• Mass Spectrometry 1
• Flow Cytometry 2
• Immunohistochemistry 3
• Liquid Biopsy 1
• Magnetic Resonance Imaging 3
• Machine Learning 4
• Cohort Studies 8
• Genome-Wide Association Study 17

• Tissue-based detection of macrophage-associated YAP1-positive material in human acute liver injury: an exploratory immunopathological biopsy series.

  Diagn Pathol, Jul 2026

• Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34.

  Int J Mol Sci, Dec 2020

• Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.

  Int J Mol Sci, Jan 2017

See which targets of this disease your abstract mentions, and go to the people working on them.